Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a berry boost your brain and lower blood pressure?

NCT ID NCT06764121

Disease control Sponsor: University of Manitoba Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a powder made from haskap berries can help lower blood pressure and improve alertness in women aged 35 and older. Thirty-two participants will take either the berry powder or a placebo for six weeks, then switch after a break. The goal is to see if this natural supplement offers real benefits for heart and brain health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Haskap berry powder
What this could lead to
If it works, this could point toward a natural supplement to help manage blood pressure and mental sharpness in women.
What could go wrong
This is a small, early-stage trial with only 32 participants. Results may not apply to everyone, and the effect may be small or not meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

32 people

The number who actually took part.

Started

Apr 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Willing and able to provide informed consent to participate in the trial; * Biological female who is at least 35 years of age; * A waist circumference of at least 35 inches; * Average systolic blood pressure between 120 and 150 mmHg; * Average diastolic blood pressure between 75 and 100 mmHg Exclusion Criteria: * Biological male; * Gluten allergies, celiac disease, or gluten intolerance; * Allergic to berries; * Receiving chemotherapy; * Use of medications containing pseudoephedrine or other anti-inflammatory drugs, and the use of cyclosporine or tacrolimusin; * Cardiovascular diseases including stroke, congestive heart failure, myocardial infarction, unstable angina pectoris, coronary artery bypass graft, percutaneous transluminal coronary angioplasty, and transient ischemic attack within six months before screening; * Inability to consume treatment product; * Inability to provide written informed consent; * Any of the following visual impairments: diabetic retinopathy, age-related macular degeneration, glaucoma, or cataract; * Risk of epileptic seizures; * Any form of motor impairments; * Any visual impairments, uncorrected vision problems, eye disorders, or injuries * Any medical condition, uncontrolled systemic disease, or concurrent illness that would hinder study compliance or jeopardize the participant's safety, based on the investigator's opinion

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alertness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alertness Hypertension

Contacts and locations

Locations

  • Richardson Centre for Food Technology and Research

    Winnipeg, Manitoba, R3T 2N2, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.